MediPharm Labs Stock Price

TSX:LABSCA$33.2mPharmaceuticals & Biotech

LABS Share Price Performance

LABS Community Fair Values

Your Fair Value
CA$
Current Price
CA$0.0883.7% undervalued intrinsic discount
Growth estimate over
Annual revenue growth rate
%/yr
Decrease
Increase
Advanced

View all narratives

Recent LABS News & Updates

MediPharm Labs Corp. Competitors

View more competitors

MediPharm Labs Corp. Key Details

Last Reported Earnings

Mar 31, 2025

Yearly revenue growth

12.82%

Earnings per share (EPS): -0.018
Gross Margin: 34.42%
Net Profit Margin: -17.37%
Debt/Equity Ratio: 0.03%

View full report ›

Canadian Market Performance

7 Days: 0.4%
3 Months: 10.0%
1 Year: 16.5%
Year to Date: 6.2%

The market has stayed flat over the 7 days. More promisingly, the market is up 16% over the past year. Looking forward, earnings are forecast to grow by 13% annually. Market details ›

🚀 Finding Moonshots in the Space Race

Richard Bowman

June 2025

The Space industry has a massive runway ahead of it, so it’s worth getting to know it if you are a long-term investor. We figured now would be a great time to check in on the industry!

Last Week

MediPharm Labs Stock Price

LABS Share Price Performance

LABS Community Fair Values

Recent LABS News & Updates

Apollo Technology Provides Information to Shareholders of MediPharm Labs

Apollo Technology Provides Information to Shareholders of MediPharm Labs

Apollo Technology Capital Provides Information to Shareholders

New minor risk - Share price stability

Apollo Technology Capital Files an Amended and Restated Information Circular

Forecast to breakeven in 2026

First quarter 2025 earnings released: CA$0.001 loss per share (vs CA$0.009 loss in 1Q 2024)

MediPharm Labs Corp. Competitors

🚀 Finding Moonshots in the Space Race

🎢 Opportunities In The Turbulent Transition To Greener Energy